Biotalys Achieves Significant Progress in Manufacturing Capabilities for Evoca
Strengthens path to market for pipeline of biocontrols to give growers access to more sustainable crop protection solutions.
Ghent, BELGIUM – 26 January 2023, 07:00 CET – Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, today announced significant progress in its manufacturing capabilities for its first biocontrol product, Evoca™*.
Biotalys’ scientists have developed multiple proprietary yeast strains increasing the production efficiency of the bioactive ingredient of Evoca by 50 to 70% in only one year, outperforming the internal targets set by the company. This achievement further strengthens the prospects of a successful path to market for the company’s pipeline of safer, more sustainable biocontrol products.
Luc Maertens, COO of Biotalys, said: “Achieving this production efficiency milestone is a crucial step forward to deliver on Biotalys’ ambition to bring effective and safe biocontrol solutions to growers worldwide at competitive cost while generating commercial value for the company. We are proud of our R&D teams, who have outperformed their goals. We will build on this achievement to further strategically expand our IP portfolio, develop Evoca and our pipeline of biocontrols produced through fermentation to replace chemical pesticides based on fossil fuels.”
*Ce communique de presse est seulement disponible en anglais.